Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,861 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
View all 290 locations
View Trial Details
Recruiting

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03969329

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Fakultni nemocnice v Motole Prague, Czechia
  • Hospices Civils de Lyon Hopital Femme Mere Enfant Bron, France
  • Hopital Armand Trousseau Paris, France
View all 23 locations
View Trial Details
Recruiting

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT04221542

Conditions
Bites and Stings, Chemically-Induced Disorders, Genital Diseases, +12 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
View all 57 locations
View Trial Details
Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

NCT07480356

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Carcinoma in Situ, +16 more
Locations
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Michael Oefelein Clinical Trials Bakersfield, California, United States
  • Renown Regional Medical Center St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

NCT06844383

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Masonic Cancer Center Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions